Prelude Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $140,706 - $166,900	201 Added 40.94%	692 $497,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $334,120 - $406,042	491 New	491 $403,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $681,412 - $799,702	-1,145 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $175,544 - $216,723	323 Added 39.29%	1,145 $723,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $668,170 - $792,637	-1,164 Reduced 58.61%	822 $497,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $938,980 - $1.11 Million	1,986 New	1,986 $1.11 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $507,485 - $622,755	-1,136 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $122,923 - $156,250	257 Added 29.24%	1,136 $549,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $212,452 - $256,701	-390 Reduced 30.73%	879 $492,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $557,944 - $728,273	1,131 Added 819.57%	1,269 $791,000
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $749,345 - $1.1 Million	-2,229 Reduced 94.17%	138 $67,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $635,981 - $873,503	2,320 Added 4936.17%	2,367 $889,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $554,576 - $645,694	-2,028 Reduced 97.73%	47 $13,000
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $462,282 - $640,067	1,543 Added 290.04%	2,075 $649,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $446,868 - $527,923	-1,201 Reduced 69.3%	532 $218,000
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $143,730 - $172,501	-428 Reduced 19.81%	1,733 $647,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $116,929 - $136,033	333 Added 18.22%	2,161 $873,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $520,248 - $630,641	1,828 New	1,828 $631,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $580,263 - $760,379	-1,618 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $697,972 - $815,472	1,618	1,618 $723,000

Others Institutions Holding REGN

# of Institutions

1,460

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$10.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$9.56 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$9.37 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.48 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$5.25 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $121B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account